National Institute of Virology

Covaxin Protects a Bit Against Beta and Delta Variants, Study Says

Covaxin and Covishield Invoked Fewer Antibodies Against B.1.617 Variant: Report

‘India Sequenced Less Than 1% of Total COVID-19 Samples in Nearly 3 Months’

Scientists Concerned About Restricted Access To Virus Database: Report

Efficacy Data Lacking for India’s COVID Vaccines Against SARS-CoV-2 Variants

10 Questions the DCGI Needs To Answer About the Two Vaccine Candidates Approved

COVID-19: Bharat Biotech’s Covaxin Expected To Be 60% Effective, Company Says